“The AABB Annual Meeting brings together the world’s foremost leaders in blood and biotherapies,” said\u00a0Michelle Mullens, Global Product Manager, Portfolio Solutions Transfusion Medicine,\u00a0at QuidelOrtho. “Our participation reinforces our dedication to driving innovation that advances laboratory performance and enhances efficiency, helping to improve patient outcomes worldwide.”<\/p>\n
Featured education sessions<\/b><\/p>\n Poster presentations<\/b><\/p>\n These posters offer insights into performance and reliability metrics that support confident decision-making in the lab.<\/p>\n Product demonstrations<\/b><\/p>\n Learn more and register<\/b><\/p>\n Explore the full agenda and secure your spot: https:\/\/cvent.me\/bA4rgD?utm_source=webmax&utm_campaign=aabb25&utm_medium=media&utm_term=register-now&RefId=media<\/a><\/p>\n About QuidelOrtho Corporation<\/p>\n With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL<\/a>) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes \u2013 from the point of care to lab, clinic to hospital. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.<\/p>\n Investor Contact: <\/b> <\/span><\/p>\n Juliet Cunningham <\/span><\/p>\n Vice President, Investor Relations <\/span><\/p>\n Media Contact: <\/b> <\/span><\/p>\n D. Nikki Wheeler <\/span><\/p>\n Senior Director, Corporate Communications <\/span><\/p>\n\n
Missing Formula: The Challenging World of Rh(D) Antigen<\/b>
Sue T. Johnson, MSTM, MLS(ASCP)SBBCM<\/sup><\/i>
An in-depth look at the complexities of Rh(D) antigen identification and its implications for transfusion safety.<\/li>\n
Identifying the Imposter: How ID-MTS Gel Test Typing Can Help Blood Banks with DARA Patients<\/b>
Lehang Dingh, MLS(ASCP)SBBCM<\/sup><\/i>
Explore how gel testing can help distinguish true antibodies from drug interference in patients treated with daratumumab.<\/li>\n
Type & Seek: Solution to the Patient Puzzle<\/b>
Shane Grimsley, DipRCPath, FBBTS, Senior Clinical Scientist, IBGRL<\/i>
Learn strategies for resolving complex serological cases using advanced immunohematology techniques.<\/li>\n<\/ul>\n\n
\n
Max Capacity. Max Efficiency.<\/i>
Built for high-throughput labs, the ORTHO VISION Max Swift Analyzer delivers speed, reliability and walkaway automation with expanded capacity for samples and reagents.<\/li>\n
Automation. Precision. Confidence.<\/i>
Simplifies transfusion testing with 98% uptime and consistent, high-quality results powered by ID-MTS\u2122 Gel Test technology.<\/li>\n
Centralized Workflow Automation.<\/i>
Supports lab networks with middleware that streamlines operations, addresses staffing challenges and helps meet compliance demands.<\/li>\n<\/ul>\n\n\n
\n \n \n
![\"\"](\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LA00458&Transmission_Id=202510162030PR_NEWS_USPR_____LA00458&DateId=20251016\")
<\/p>\n<\/div>\n